LSI Alumni companies recorded $1.0 billion in funding and strategic transactions during Q3 2026, spanning venture financings, acquisitions, strategic partnerships, debt financings, grants, and other transactions across the medtech ecosystem.
The quarter included four acquisitions, led by iRhythm Technologies’ $287.5 million acquisition of VitalConnect and Enovis’ €155 million acquisition of eCential Robotics. Other notable financing rounds included Xenter at $58.3 million, Anaconda BioMed at $56 million, and Implicity at $40 million.
Strategic activity extended beyond traditional financings. The quarter included strategic activity involving Axogen and Trace Biosciences, KARL STORZ and Moon Surgical, and Denka and FloSonics Medical. Four companies also secured debt financing: Carvolix Medical (€30 million), Neurent Medical (€25 million), TENSIVE (up to €20 million), and THINK Surgical (up to $65 million).
The complete Q3 2026 LSI Alumni Funding Report provides a closer look at the funding and strategic activity tracked across the LSI Alumni community, including companies such as Materna Medical, Azalea Vision, TYBR Health, Zepto Life Technology, and many more.
The report includes deal types, technology descriptions, investors, and transaction details, disclosed amounts, dates, and direct links to company profiles in Compass AI.
Join the LSI Mailing List
Upcoming Events
17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647
© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data